These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 22963010)

  • 1. Low luminance visual acuity in patients with central serous chorioretinopathy.
    Fujita K; Shinoda K; Matsumoto CS; Imamura Y; Mizutani Y; Tanaka E; Mizota A; Oda K; Yuzawa M
    Clin Exp Optom; 2013 Jan; 96(1):100-5. PubMed ID: 22963010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
    BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical factors related to visual outcome in central serous chorioretinopathy.
    Aggio FB; Roisman L; Melo GB; Lavinsky D; Cardillo JA; Farah ME
    Retina; 2010; 30(7):1128-34. PubMed ID: 20616688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal adaptability loss in serous retinal detachment with central serous chorioretinopathy.
    Shimada Y; Imai D; Ota Y; Kanai K; Mori K; Murayama K; Yoneya S
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3210-5. PubMed ID: 20164451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early changes in foveal thickness in eyes with central serous chorioretinopathy.
    Hata M; Oishi A; Shimozono M; Mandai M; Nishida A; Kurimoto Y
    Retina; 2013 Feb; 33(2):296-301. PubMed ID: 23023530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of spectral domain optical coherence tomography findings and visual acuity in central serous chorioretinopathy.
    Yalcinbayir O; Gelisken O; Akova-Budak B; Ozkaya G; Gorkem Cevik S; Yucel AA
    Retina; 2014 Apr; 34(4):705-12. PubMed ID: 24100708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy.
    Ooto S; Hangai M; Sakamoto A; Tsujikawa A; Yamashiro K; Ojima Y; Yamada Y; Mukai H; Oshima S; Inoue T; Yoshimura N
    Ophthalmology; 2010 Sep; 117(9):1800-9, 1809.e1-2. PubMed ID: 20673590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab injection for central serous chorioretinopathy.
    Lim SJ; Roh MI; Kwon OW
    Retina; 2010 Jan; 30(1):100-6. PubMed ID: 20010322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does microperimetry have a prognostic value in central serous chorioretinopathy?
    Roisman L; Ribeiro JC; Fechine FV; Lavinsky D; Moraes N; Campos M; Farah ME
    Retina; 2014 Apr; 34(4):713-8. PubMed ID: 23975001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subretinal dot-like precipitates and yellow material in central serous chorioretinopathy.
    Maruko I; Iida T; Ojima A; Sekiryu T
    Retina; 2011 Apr; 31(4):759-65. PubMed ID: 21052035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of smoking on visual acuity of central serous chorioretinopathy patients.
    Türkcü FM; Yüksel H; Sahin A; Cinar Y; Cingü K; Arı S; Sahin M; Altındağ S; Caça I
    Cutan Ocul Toxicol; 2014 Jun; 33(2):115-9. PubMed ID: 23841829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annular Lesions and Catenary Forms in Chronic Central Serous Chorioretinopathy.
    Dansingani KK; Balaratnasingam C; Mrejen S; Inoue M; Freund KB; Klancnik JM; Yannuzzi LA
    Am J Ophthalmol; 2016 Jun; 166():60-67. PubMed ID: 27021439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations among various functional and morphological tests in resolved central serous chorioretinopathy.
    Kim SW; Oh J; Huh K
    Br J Ophthalmol; 2012 Mar; 96(3):350-5. PubMed ID: 21617156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between kinetic visual acuity and visual acuity with limited exposure].
    Niwa K; Okuyama F; Tokoro T
    Nippon Ganka Gakkai Zasshi; 1995 Sep; 99(9):1045-51. PubMed ID: 7484506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central serous chorioretinopathy treated with navigated retinal laser photocoagulation: visual acuity and retinal sensitivity.
    Mastropasqua L; Di Antonio L; Toto L; Mastropasqua A; Di Iorio A; Carpineto P
    Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):349-54. PubMed ID: 25856822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study.
    Artunay O; Yuzbasioglu E; Rasier R; Sengul A; Bahcecioglu H
    Curr Eye Res; 2010 Feb; 35(2):91-8. PubMed ID: 20136418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of one-year follow-up examinations after intravitreal bevacizumab administration for chronic central serous chorioretinopathy.
    Inoue M; Kadonosono K; Watanabe Y; Kobayashi S; Yamane S; Arakawa A
    Ophthalmologica; 2011; 225(1):37-40. PubMed ID: 20693820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography.
    Song IS; Shin YU; Lee BR
    Am J Ophthalmol; 2012 Aug; 154(2):366-375.e4. PubMed ID: 22633348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series.
    Salz DA; Pitcher JD; Hsu J; Regillo CD; Fineman MS; Elliott KS; Vander JF; Fischer DH; Spirn MJ
    Ophthalmic Surg Lasers Imaging Retina; 2015 Apr; 46(4):439-44. PubMed ID: 25970864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fundus autofluorescence and visual acuity in central serous chorioretinopathy.
    Imamura Y; Fujiwara T; Spaide RF
    Ophthalmology; 2011 Apr; 118(4):700-5. PubMed ID: 21055816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.